To determine the role of CXCR2 signaling in the tumor-bone interface, we utilized an experimental osteolytic bone metastasis model; implanting the breast cancer cells on the dorsal calvaria of mice and evaluating the tumor growth, bone destruction index, and osteoclast activation (Figure 1A). Here, CXCR2 is linked to breast cancer.